The University of Maine Institutional Biosafety Committee (IBC) has issued minor revisions to the Policies and Procedures for Research Involving Recombinant or Synthetic Nucleic Acid Molecules or Infectious Agents (Word). These revisions reflect the recent updates to the National Institutes of Health (NIH) Guidelines (issued April 2024) and the revised United States Government Policy for […]
Read more
The National Institutes of Health (NIH) has issued revisions to the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (external link) as of April 2024 – these revisions will become effective on September 30, 2024. The revisions include: More details about these revisions are available in the Federal Register Notice: Final Action […]
Read more
The following message was sent via email to all University of Maine employees on March 20, 2023 by the Office of the Vice President for Research and Dean of the Graduate School. The Office of Research Compliance has worked with the Biosafety Officer, Dr. Andy Holmes, and the Institutional Biosafety Committee (IBC) to review and […]
Read more